|
⚲
|
| Keyboard |
| Biocryst Pharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0000882796 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0000882796] | |
| 10-Q | [0000882796] | |
| 3 | [0000882796] | |
| 4 | [0000882796] | |
| 8-K | [0000882796] | |
| SC 13D | [0000882796] | |
| SC 13G | [0000882796] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Milano Vincent | |
| Biocryst Pharmaceuticals Inc | |
| Sanders Machelle | |
| Milne Jill C | |
| Galson Steven K | |
| Levin Alan G | |
| Frank Steven | |
| Heggie Theresa | |
| McKee Amy E | |
| Stonehouse Jon P | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-03-20 | Sell | 49,933 | $10.11 | 504,823 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-03-20 | Option exercise | 49,933 | $6.30 | 314,578 |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2026-03-20 | Option exercise | 49,933 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-03-16 | Option exercise | 150,000 | $5.51 | 826,500 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 150,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-03-16 | Sell | 150,000 | $9.15 | 1,372,500 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2026-03-02 | Option exercise | 305,995 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-03-02 | Disposed to issuer | 305,995 | $8.64 | 2,643,797 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-03-02 | Option exercise | 305,995 | $3.22 | 985,304 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-02-27 | Grant | 642 | $8.75 | 5,618 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-02-27 | Grant | 421 | $8.75 | 3,684 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-02-27 | Grant | 1,285 | $8.75 | 11,244 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-02-27 | Grant | 528 | $8.75 | 4,620 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-02-27 | Grant | 848 | $8.75 | 7,420 |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2026-01-23 | Grant | 26,684 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-01-23 | Grant | 2,582 | ||
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-01-23 | Grant | 12,272 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-12-22 | Option exercise | 14,142 | $3.22 | 45,537 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2025-12-22 | Option exercise | 50,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-12-22 | Option exercise | 10,091 | $5.04 | 50,859 |
| showing 20 of 200 most recent transactions | |||||